Skip to main content
logo
Brii Biosciences Limited (HKG:2137)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.9600
-0.0700 (-6.80%)
Aug 27, 2026, 4:08 PM HKT

Brii Biosciences Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
7431,0177171,6635,35923,698
Market Cap Growth
-47.82%41.89%-56.90%-68.97%-77.38%-
Enterprise Value
-1,353-1,305-1,880-1,3351,55129,354
Last Close Price
1.031.410.982.287.3732.90

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
18.4825.7113.4927.0138.77208.62
PB Ratio
0.300.390.260.491.505.83
P/TBV Ratio
0.330.440.270.531.565.79

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
----11.22258.41

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.000.000.010.000.000.01
Net Debt / Equity Ratio
-0.81-0.83-0.88-0.86-0.94-1.01
Net Debt / EBITDA Ratio
6.726.755.714.945.905.53
Net Debt / FCF Ratio
-5.676.104.476.013.79
Asset Turnover
0.020.010.020.020.040.04
Quick Ratio
51.7960.0229.9721.7013.3312.13
Current Ratio
52.2460.7331.1822.1113.4312.16
Return on Equity (ROE)
-7.67%-9.09%-18.05%-5.92%-15.14%-534.39%
Return on Assets (ROA)
-7.02%-7.08%-8.55%-10.33%-9.17%-15.64%
Return on Capital Employed (ROCE)
-12.20%-12.30%-15.40%-17.70%-16.20%-18.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-27.19%-24.36%-75.46%-11.58%-10.22%-21.57%
FCF Yield
--37.26%-55.85%-39.35%-10.47%-4.56%
Buyback Yield / Dilution
-0.02%1.15%-0.29%-0.64%-64.78%-129.57%